The oncometabolite 2-hydroxyglutarate activates the mTOR signalling pathway
Mélissa Carbonneau(Hôpital Maisonneuve-Rosemont), Frédérick A. Mallette(Hôpital Maisonneuve-Rosemont)
Cited by 179
Related Papers
RNF8‐ and RNF168‐dependent degradation of KDM4A/JMJD2A triggers 53BP1 recruitment to DNA damage sites
|The EMBO Journal|2012|345
<i>R</i>-2-hydroxyglutarate-mediated inhibition of KDM4A compromises telomere integrity
|Nucleic Acids Research|2025|4